Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells

A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes

(2012) Sibylle Haid et al.   GASTROENTEROLOGY

Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals

(2012) Haihong Zhu et al.   JOURNAL OF INFECTIOUS DISEASES

Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

(2012) Bruno Sainz et al.   NATURE MEDICINE

Bile Acids Specifically Increase Hepatitis C Virus RNA-Replication

(2012) Patrick Chhatwal et al.   PLoS One

Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture

(2012) Glen A. Coburn et al.   PLoS One

In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog

(2012) Haitao Liu et al.   PLoS One

Griffithsin Has Antiviral Activity against Hepatitis C Virus

(2011) Philip Meuleman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

(2011) Sandra Ciesek et al.   HEPATOLOGY

(−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry

(2011) Noémie Calland et al.   HEPATOLOGY

Curcumin and its nano-formulation: The kinetics of tissue distribution and blood–brain barrier penetration

(2011) Yin-Meng Tsai et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

A genetically humanized mouse model for hepatitis C virus infection

(2011) Marcus Dorner et al.   NATURE

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

(2011) Joachim Lupberger et al.   NATURE MEDICINE

Evolving epidemiology of hepatitis C virus

(2010) D. Lavanchy   CLINICAL MICROBIOLOGY AND INFECTION

Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus

(2010) Sandra Ciesek et al.   GASTROENTEROLOGY

Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation

(2010) A. Baghdasaryan et al.   GUT

Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats

(2010) Jian-Mei Li et al.   HEPATOLOGY

Retransplantation in patients with hepatitis C recurrence after liver transplantation

(2010) José A. Carrión et al.   JOURNAL OF HEPATOLOGY

Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies

(2010) Mirjam B. Zeisel et al.   JOURNAL OF HEPATOLOGY

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

(2010) Christopher T Jones et al.   NATURE BIOTECHNOLOGY

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

(2010) M. R. St.Vincent et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry

(2010) Carl J. Baldick et al.   PLoS Pathogens

Cellular and molecular biology of HCV infection and hepatitis

(2009) Hengli Tang et al.   CLINICAL SCIENCE

Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway

(2009) KyeongJin Kim et al.   FEBS LETTERS

Determining the Effects of Lipophilic Drugs on Membrane Structure by Solid-State NMR Spectroscopy: The Case of the Antioxidant Curcumin

(2009) Jeffrey Barry et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Curcumin and cancer: An “old-age” disease with an “age-old” solution

(2008) Preetha Anand et al.   CANCER LETTERS

Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition

(2008) D G Binion et al.   GUT

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs

(2008) Judith M. Gottwein et al.   HEPATOLOGY

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

(2008) J. Witteveldt et al.   JOURNAL OF GENERAL VIROLOGY

Highly Efficient JFH1‐Based Cell‐Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing‐Antibody Treatment to Control Infection

(2008) Tanja B. Jensen et al.   JOURNAL OF INFECTIOUS DISEASES

Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

(2008) T. K. H. Scheel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA